Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutations
Isabel Montesinos(Université Libre de Bruxelles), Olivier Denis(Université Libre de Bruxelles), Farida Ajjaham(Erasmus Hospital), Maya Hites(Université Libre de Bruxelles), Marie‐Luce Delforge(Erasmus Hospital), Françoise Brancart(Université Libre de Bruxelles), Frédérique Jacobs(Université Libre de Bruxelles)
Cited by 45
Related Papers
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
|The Lancet|2007|689
Deep Dermatophytosis and Inherited CARD9 Deficiency
|New England Journal of Medicine|2013|403
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock
|Critical Care|2010|372
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
|The Lancet Infectious Diseases|2021|344
Impact of Infectious Diseases Specialists and Microbiological Data on the Appropriateness of Antimicrobial Therapy for Bacteremia
|Clinical Infectious Diseases|1999|266